489
Views
9
CrossRef citations to date
0
Altmetric
Review

Novel therapeutic targets and predictive markers for hepatocellular carcinoma

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yan Yan, Ningbo Chen, Yunbing Wang & Ke Wang. (2016) The application of antitumor drug-targeting models on liver cancer. Drug Delivery 23:5, pages 1667-1675.
Read now

Articles from other publishers (8)

Stephen L Chan, Nathalie Wong, W K Jacky Lam & Ming Kuang. (2022) Personalized treatment for hepatocellular carcinoma: Current status and future perspectives. Journal of Gastroenterology and Hepatology 37:7, pages 1197-1206.
Crossref
Tao Wang, Zhiying Hou, Xinyuan Chen, Li Zhao, Deqi Zhu, Ning Wang, Yufen Zhao & Bin Zhang. (2022) Analysis of the medication rules of traditional Chinese medicines (TCMs) in treating liver cancer and potential TCMs exploration. Pharmacological Research - Modern Chinese Medicine 3, pages 100086.
Crossref
Stephen L. Chan, Paul N.M. Cheng, Angela M. Liu, Landon L. Chan, Leung Li, Cheuk M. Chu, Charing C.N. Chong, Yat M. Lau, Winnie Yeo, Kelvin K.C. Ng, Simon C.H. Yu, Tony S.K. Mok & Anthony W.H. Chan. (2021) A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma. Investigational New Drugs 39:5, pages 1375-1382.
Crossref
Zhen Wang, Yan-Jiang Han, Shun Huang, Meng Wang, Wen-Lan Zhou, Hong-Sheng Li, Quan-Shi Wang & Hu-Bing Wu. (2017) Imaging the expression of glypican-3 in hepatocellular carcinoma by PET. Amino Acids 50:2, pages 309-320.
Crossref
Yao-Li Chen, Shih-Hsuan Chan, Ping-Yi Lin & Pei-Yi Chu. (2017) The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients. Human Pathology 63, pages 212-216.
Crossref
Anthony W. H. Chan & Ka-Fai To. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 349 372 .
Stephen L. Chan, Alissa M. Wong, Kirsty Lee, Nathalie Wong & Allen K.C. Chan. (2016) Personalized therapy for hepatocellular carcinoma: Where are we now?. Cancer Treatment Reviews 45, pages 77-86.
Crossref
Anthony W. H. Chan & Ka-Fai To. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 24 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.